| Year |
Citation |
Score |
| 2019 |
Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T, Zhang Z, Li W, Lee H, Aftabizadeh M, Li YJ, Lee PP, Forman S, Somlo G, Chu P, et al. STAT3 Activation-Induced Fatty Acid Oxidation in CD8 T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth. Cell Metabolism. PMID 31761565 DOI: 10.1016/J.Cmet.2019.10.013 |
0.393 |
|
| 2019 |
Herrmann A, Nagao T, Zhang C, Lahtz C, Li YJ, Yue C, Mülfarth R, Yu H. An effective cell-penetrating antibody delivery platform. Jci Insight. 4. PMID 31341104 DOI: 10.1172/Jci.Insight.127474 |
0.353 |
|
| 2017 |
Deng R, Hurtz C, Song Q, Yue C, Xiao G, Yu H, Wu X, Muschen M, Forman S, Martin PJ, Zeng D. Extrafollicular CD4(+) T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease. Nature Communications. 8: 978. PMID 29042531 DOI: 10.1038/S41467-017-00880-2 |
0.331 |
|
| 2017 |
Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, Yue C, Look T, Muelfarth R, Li W, Jenkins K, Williams J, Budde LE, Forman SJ, Kwak LW, et al. CTLA4 promotes Tyk2-STAT3 dependent B cell oncogenecity. Cancer Research. PMID 28716895 DOI: 10.1158/0008-5472.Can-16-0342 |
0.517 |
|
| 2015 |
Yue C, Shen S, Deng J, Priceman SJ, Li W, Huang A, Yu H. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis. Cancer Immunology Research. PMID 26025380 DOI: 10.1158/2326-6066.Cir-15-0014 |
0.439 |
|
| 2015 |
Yue C, Xu J, Tan Estioko MD, Kotredes KP, Lopez-Otalora Y, Hilliard BA, Baker DP, Gallucci S, Gamero AM. Host STAT2/type I interferon axis controls tumor growth. International Journal of Cancer. 136: 117-26. PMID 24895110 DOI: 10.1002/Ijc.29004 |
0.68 |
|
| 2015 |
Deng R, Hurtz C, Yue C, Xiao G, Yu H, Muschen M, Forman SJ, Martin PJ, Zeng D. Extrafollicular CD4+ T and B Interaction Induces Chronic Gvhd in the Absence of Germinal Center Formation Blood. 126: 1875-1875. DOI: 10.1182/Blood.V126.23.1875.1875 |
0.315 |
|
| 2014 |
Priceman SJ, Shen S, Wang L, Deng J, Yue C, Kujawski M, Yu H. S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. Cell Reports. 6: 992-9. PMID 24630990 DOI: 10.1016/J.Celrep.2014.02.016 |
0.493 |
|
| 2012 |
Yue C, Soboloff J, Gamero AM. Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells. The Journal of Biological Chemistry. 287: 3207-16. PMID 22144678 DOI: 10.1074/Jbc.M111.269068 |
0.608 |
|
| 2012 |
Yue C, Gamero AM. Abstract 3994: Loss of STAT2 enhances the establishment of B16 melanoma tumors Cancer Research. 72: 3994-3994. DOI: 10.1158/1538-7445.Am2012-3994 |
0.672 |
|
| 2012 |
Yue C, Xu J, Gallucci S, Gamero A. P058 A requirement for type I interferon/Stat2 signals in restricting the establishment of melanoma Cytokine. 59: 537. DOI: 10.1016/J.Cyto.2012.06.143 |
0.684 |
|
| 2011 |
Yue C, Gamero AM. PS1-099 Loss of STAT2 enhances the establishment of B16 melanoma tumors. Cytokine. 56: 42. DOI: 10.1016/J.Cyto.2011.07.131 |
0.634 |
|
| 2010 |
Ritchie MF, Yue C, Zhou Y, Houghton PJ, Soboloff J. Wilms tumor suppressor 1 (WT1) and early growth response 1 (EGR1) are regulators of STIM1 expression Journal of Biological Chemistry. 285: 10591-10596. PMID 20123987 DOI: 10.1074/Jbc.M109.083493 |
0.461 |
|
| 2010 |
Yue C, Soboloff J, Gamero AM. PS3-29 A defect in store-operated calcium entry sensitizes T cells to Type I interferon-induced apoptosis Cytokine. 52: 87-88. DOI: 10.1016/J.Cyto.2010.07.368 |
0.579 |
|
| Show low-probability matches. |